These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 21601338)

  • 41. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
    Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
    Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of simultaneous PET/MR imaging in the head and upper neck area.
    Boss A; Stegger L; Bisdas S; Kolb A; Schwenzer N; Pfister M; Claussen CD; Pichler BJ; Pfannenberg C
    Eur Radiol; 2011 Jul; 21(7):1439-46. PubMed ID: 21308378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
    Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET/MR in cancers of the head and neck.
    Queiroz MA; Huellner MW
    Semin Nucl Med; 2015 May; 45(3):248-65. PubMed ID: 25841279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis.
    Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
    J Nucl Med; 2012 Jun; 53(6):928-38. PubMed ID: 22582048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].
    Nakasone Y; Mogi K; Endo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):258-64. PubMed ID: 12073631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical usefulness of [18F]FDG PET-CT and CT/MRI for detecting nodal metastasis in patients with hypopharyngeal squamous cell carcinoma.
    Shin NY; Lee JH; Kang WJ; Koh YW; Sohn B; Kim J
    Ann Surg Oncol; 2015 Mar; 22(3):994-9. PubMed ID: 25201502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
    Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
    PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
    Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The value of PET-CT imaging in malignant tumours of the head and neck].
    Balink H; Krabbe CA; de Visscher JG
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Sekine T; Barbosa FG; Delso G; Burger IA; Stolzmann P; Ter Voert EE; Huber GF; Kollias SS; von Schulthess GK; Veit-Haibach P; Huellner MW
    Head Neck; 2017 Aug; 39(8):1550-1558. PubMed ID: 28500749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New directions in head and neck imaging.
    Shah GV; Wesolowski JR; Ansari SA; Mukherji SK
    J Surg Oncol; 2008 Jun; 97(8):644-8. PubMed ID: 18493943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors.
    Zanation AM; Sutton DK; Couch ME; Weissler MC; Shockley WW; Shores CG
    Laryngoscope; 2005 Jul; 115(7):1186-90. PubMed ID: 15995504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
    Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
    J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.